222 related articles for article (PubMed ID: 35311612)
1. Is hepatocellular carcinoma complicated with portal vein tumor thrombosis potentially curable by radiotherapy in the form of stereotactic body radiation therapy?
Srivastava A; Parambath HK; Ramdulari AV; Saxena H; Kumar R; Pandey S; Shalimar ; Gupta S; Jee B
Int J Radiat Biol; 2022; 98(10):1495-1509. PubMed ID: 35311612
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis.
Shui Y; Yu W; Ren X; Guo Y; Xu J; Ma T; Zhang B; Wu J; Li Q; Hu Q; Shen L; Bai X; Liang T; Wei Q
Radiat Oncol; 2018 Sep; 13(1):188. PubMed ID: 30253783
[TBL] [Abstract][Full Text] [Related]
3. Comparison of stereotactic body radiation therapy with and without sorafenib as treatment for hepatocellular carcinoma with portal vein tumor thrombosis.
Que J; Wu HC; Lin CH; Huang CI; Li LC; Ho CH
Medicine (Baltimore); 2020 Mar; 99(13):e19660. PubMed ID: 32221093
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors for survival following stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumour thrombosis and construction of a nomogram.
Li X; Ye Z; Lin S; Pang H
BMC Cancer; 2021 Jun; 21(1):701. PubMed ID: 34126955
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombosis.
Xi M; Zhang L; Zhao L; Li QQ; Guo SP; Feng ZZ; Deng XW; Huang XY; Liu MZ
PLoS One; 2013; 8(5):e63864. PubMed ID: 23737955
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Stereotactic Body Radiotherapy to Portal Vein Tumour Thrombus in Hepatocellular Carcinoma: Clinical and Pathological Analysis.
Kishi N; Kanayama N; Hirata T; Ohira S; Wada K; Kawaguchi Y; Konishi K; Nagata S; Nakatsuka SI; Marubashi S; Tomokuni A; Wada H; Kobayashi S; Tomita Y; Teshima T
Sci Rep; 2020 Mar; 10(1):4105. PubMed ID: 32139751
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of stereotactic body radiotherapy for portal vein tumor thrombosis in patients with hepatocellular carcinoma and underlying chronic liver disease.
Choi HS; Kang KM; Jeong BK; Jeong H; Lee YH; Ha IB; Song JH
Asia Pac J Clin Oncol; 2021 Jun; 17(3):209-215. PubMed ID: 32757461
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area.
Im JH; Yoon SM; Park HC; Kim JH; Yu JI; Kim TH; Kim JW; Nam TK; Kim K; Jang HS; Kim JH; Kim MS; Yoon WS; Jung I; Seong J
Liver Int; 2017 Jan; 37(1):90-100. PubMed ID: 27317941
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis/inferior vena cava tumor thrombosis: evaluation by comparison with conventional three-dimensional conformal radiotherapy.
Matsuo Y; Yoshida K; Nishimura H; Ejima Y; Miyawaki D; Uezono H; Ishihara T; Mayahara H; Fukumoto T; Ku Y; Yamaguchi M; Sugimoto K; Sasaki R
J Radiat Res; 2016 Sep; 57(5):512-523. PubMed ID: 27053259
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis.
Choi BO; Choi IB; Jang HS; Kang YN; Jang JS; Bae SH; Yoon SK; Chai GY; Kang KM
BMC Cancer; 2008 Nov; 8():351. PubMed ID: 19038025
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].
Wu DH; Chen LH
Ai Zheng; 2004 Jul; 23(7):825-8. PubMed ID: 15248921
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiotherapy versus intensity-modulated radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis.
Li LQ; Zhou Y; Huang Y; Liang P; Liang SX; Su TS
Hepatol Int; 2021 Jun; 15(3):630-641. PubMed ID: 33818714
[TBL] [Abstract][Full Text] [Related]
13. Comparison of stereotactic body radiation therapy versus fractionated radiation therapy for primary liver cancer with portal vein tumor thrombus.
Zhang S; He L; Bo C; Yang S; An Y; Li N; Zhao Y; Zhao L; Ma W; Zheng Z
Radiat Oncol; 2021 Aug; 16(1):149. PubMed ID: 34391452
[TBL] [Abstract][Full Text] [Related]
14. Prognostic index for portal vein tumor thrombosis in patients with hepatocellular carcinoma treated with radiation therapy.
Yu JI; Park HC; Lim DH; Park W; Yoo BC; Paik SW; Koh KC; Lee JH
J Korean Med Sci; 2011 Aug; 26(8):1014-22. PubMed ID: 21860551
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional conformal radiotherapy for locally advanced hepatocellular carcinoma with portal vein tumour thrombosis: evaluating effectiveness of the model for end-stage liver disease (MELD) score compared with the Child-Pugh classification.
Okazaki E; Yamamoto A; Nishida N; Hamuro M; Ogino R; Hosono M; Shimatani Y; Tsutsumi S; Hamamoto S; Sohgawa E; Jogo A; Miki Y
Br J Radiol; 2016 Jul; 89(1063):20150945. PubMed ID: 27164029
[TBL] [Abstract][Full Text] [Related]
16. INTRABEAM intraoperative radiotherapy combined with portal vein infusion chemotherapy for treating hepatocellular carcinoma with portal vein tumor thrombus.
Song X; He Y; Liang H; Han M; Shao Z
BMC Surg; 2020 Aug; 20(1):174. PubMed ID: 32738882
[TBL] [Abstract][Full Text] [Related]
17. I
Li S; Guo JH; Lu J; Wang C; Wu H; Wang H; Zha J; Fan R
Cancer Radiother; 2021 Jun; 25(4):340-349. PubMed ID: 33455874
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis.
Yu JI; Park HC
World J Gastroenterol; 2016 Aug; 22(30):6851-63. PubMed ID: 27570422
[TBL] [Abstract][Full Text] [Related]
19. [A Case of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Treated Successfully with Multidisciplinary Therapy Including Preoperative Stereotactic Body Radiotherapy(SBRT)].
Nishimura S; Tomokuni A; Kobayashi S; Asukai K; Akita H; Takahashi H; Yanagimoto Y; Takahashi Y; Miyoshi N; Sugimura K; Yamamoto K; Ohmori T; Ohue M; Yano M; Sakon M
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1650-1652. PubMed ID: 29394731
[TBL] [Abstract][Full Text] [Related]
20. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
